Nolato AB (publ) (FRA:NBF)

Blueprint Medicines Revenue

Nolato AB had revenue of 2.40B SEK in the quarter ending June 30, 2025, a decrease of -1.80%. This brings the company's revenue in the last twelve months to 9.63B, up 1.67% year-over-year. In the year 2024, Nolato AB had annual revenue of 9.66B with 1.24% growth.

• Revenue (ttm): 9.63B SEK
• Revenue Growth: +1.67%
• P/S Ratio: 1.59
• Revenue / Employee: 1.65M SEK
• Employees: 5,837
• Market Cap: 1.37B USD

Revenue Chart

* This company reports financials in SEK.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	9.66B	118.00M	1.24%
Dec 31, 2023	9.55B	-1.23B	-11.40%
Dec 31, 2022	10.77B	-836.00M	-7.20%
Dec 31, 2021	11.61B	2.25B	24.05%
Dec 31, 2020	9.36B	1.44B	18.18%